In recent years, we have seen an increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on content…
Tampons from several brands, potentially used by millions of people each month, can contain toxic metals like lead, arsenic, and cadmium, according to a new study led by a UC Berkeley researcher. Tampons are a particular concern as a potential source of chemical exposure because the vaginal skin has a higher potential for chemical absorption than skin elsewhere on the body. Additionally,…
A study presented at the recent ESHRE Annual Meeting in Amsterdam has shown that exposure to fine particulate matter (PM) before the retrieval of oocytes during in vitro fertilisation (IVF) can reduce the odds of achieving a live birth by almost 40%. The research, conducted over eight years in Perth, Australia, analyzed 3,659 frozen embryo transfers from 1,836 patients. It found that…
The European Society of Human Reproduction and Embryology (ESHRE) has launched the Female Reproductive Genetics Initiative (FeRGI), a project aimed at translating genetic research in infertility into clinical practice. Developed within the Special Interest Group (SIG) Reproductive Genetics, FeRGI focuses on providing resources and training to clinicians and biologists to improve the diagnosis and treatment of female infertility. Recent advancements over the…
At the ESHRE Annual Meeting in Amsterdam, data presented revealed that women in Europe are undergoing more cycles of in vitro fertilisation (IVF) and intrauterine insemination (IUI). The data from the ESHRE European IVF Monitoring (EIM) Consortium indicates a steady rise in the use of Assisted Reproductive Technology (ART). In 2021, a total of 1,103,633 ART treatment cycles were reported by 1,382…
It’s 2024. We still don’t know what causes PCOS. We don’t know how to cure it. And we have a limited understanding how to treat it properly. PCOS stands for Polycystic Ovary Syndrome. It’s a syndrome because we don’t really understand it. It’s a syndrome because in medicine ‘syndrome’ refers to a group or collection of symptoms and signs that consistently occur…
Oxolife, a biotech company specializing in female fertility, has announced promising results from a Phase 2 clinical trial of its non-hormonal fertility pill, OXO-001, at the European Society of Human Reproduction and Embryology (ESHRE) 40th Annual Meeting in Amsterdam. The data indicates that OXO-001 significantly improves embryo implantation, pregnancy, and live birth rates in women undergoing in-vitro fertilization (IVF) and intracytoplasmic sperm…
In recent years, we have seen an increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on content and…